News from qed therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 03, 2019, 08:00 ET QED Therapeutics Presents New Data on the Potential for Infigratinib to Treat Upper Tract Urothelial Carcinoma

QED Therapeutics announced today the presentation of data demonstrating the clinical activity of its investigational product infigratinib in advanced ...


Apr 01, 2019, 13:00 ET Preclinical Data Demonstrates the Potential of QED Therapeutics' Infigratinib in Multiple FGFR+ Tumor Types

QED Therapeutics announced today the presentation of preclinical data demonstrating the potential of infigratinib for treating FGFR-driven cancers...


Dec 10, 2018, 08:00 ET QED Therapeutics Announces a Collaboration with Foundation Medicine to Develop Companion Diagnostics for Infigratinib

QED Therapeutics today announced that it has entered into an agreement with Foundation Medicine to develop a companion diagnostic for infigratinib,...


Oct 19, 2018, 10:50 ET QED Therapeutics Presents Data for Infigratinib in Cholangiocarcinoma in Late Breaking Abstract at the European Society of Medical Oncology 2018 Congress

QED Therapeutics today announced the presentation of positive, updated interim data of infigratinib (BGJ398), an orally administered, selective...